Brooke M. Faught, DNP, WHNP-BC, IF
Women's Institute for Sexual Health
Susan Kellogg-Spadt, PhD, CRNP, IF, FCST, CSC
Director, Female Sexual Medicine
Center for Pelvic Medicine
Bryn Mawr, Pennsylvania
Nurse practitioners (NPs), Certified Nurse-Midwives (CNMs), and other advanced practice clinicians who care for women.
- CE Approval Period: Now through December 2019
- Estimated Time to Complete This Activity: 3.5 hours
- CE Approval Hours: 3.5 Contact Hours of CE Credit including 1.5 contact hours of pharmacology credit
At the conclusion of this activity, clinicians should be better able to:
- Appropriately use screening tools to assess for sexual dysfunction in the clinical setting.
- Utilize methods for normalizing the use of sexual aids and toys in professional conversations with patients.
- Understand the difference between typical markings of BDSM play and abuse.
- Recognize important aspects of managing sexual health in LGBTQI patients.
- Implement new and emerging therapies for female sexual conditions.
Successful Completion of the Activity:
Successful completion of this online activity, 18-04-01, requires the participant to:
During the approval period (now through December 2019);
- Read the educational objectives, disclosures, and disclaimers on the front page;
- Study the material in the learning activity by watching the session;
- Complete the post test with a score of 70% or higher;
- Complete the session evaluation;
- After successful completion you may print your CE certificate. Your certificate will be stored for you on the NPWH E-Learning site under My Transcripts
This four hour pre-conference will cover sensitive topics in sexual medicine by two sexual medicine experts. Content will include sexual history taking, alternative sexual practices, normalizing the use of sexual aids and toys, sexuality in LGBTQI patients, and new and emerging therapies in sexual medicine.
This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health (NPWH), and has been approved for 3.5 contact hour(s) of CE credit including 1.5 contact hours of pharmacology credit. Each participant should claim only those contact hours that he/she actually spent in the educational activity.
Activity Number: 18-04-01
NPWH policy requires all faculty to disclose any affiliation or relationship with a commercial interest that may cause a potential, real, or apparent conflict of interest with the content of a CE program. NPWH does not imply that the affiliation or relationship will affect the content of the CE program. Disclosure provides participants with information that may be important to their evaluation of an activity. All conflicts of interest were resolved according to NPWH policy. In addition, all content has been peer reviewed by a WHNP with no conflicts of interest to ensure the content is evidence-based, un-biased, and uses the best available, highest strength evidence for recommendations. Faculty are also asked to identify any unlabeled/unapproved uses of drugs or devices made in their presentation.
Brooke M. Faught, DNP, WHNP-BC, IF, has disclosed that she receives consulting fees from Duchesnay, Lupin, AMAG. She has also received promotional fees from AMAG. Dr. Faught has also done contractual research with IPSEN Innovations.
Susan Kellogg-Spadt, PhD, CRNP, IF, FCST, CSC has disclosed that she receives consulting fees from AMAG, Duchesnay, Aytu, Materna, and DEKA.
Disclosure of unlabeled use:
NPWH policy requires authors to disclose to participants when presenting information about unlabeled use of a commercial product or device or an investigational use of a drug or device not yet approved for any use.
Participating faculty members determine the editorial content of CE activities; this content does not necessarily represent the views of NPWH. This content has undergone a blinded peer review process for validation of clinical content. Although every effort has been made to ensure that the information is accurate, clinicians are responsible for evaluating this information in relation to generally accepted standards in their own communities and integrating the information in this activity with that of established recommendations of other authorities, national guidelines, FDA approved package inserts, and individual patient characteristics.
This activity was supported by an educational grant from AMAG Pharmaceuticals.
You must be signed in to access this course. You can sign in at the top right-hand corner of the page.
**If you are an NPWH member, were once a member, or have taken CE activities with NPWH in the past, you have a username and password in our new system. Please DO NOT create a new account. Creation of multiple accounts could result in loss of CE credits as well as other NPWH services. If you do not remember your username or password, please either click on the "forgot username" or "forgot password" links at the bottom of the sign in screen or call the NPWH office at (202) 543-9693 ext. 1.**